# A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

> **NCT00742261** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** GSK1363089

## Key facts

- **NCT ID:** NCT00742261
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-11
- **Primary completion:** 2009-06-24
- **Final completion:** 2009-06-24
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742261, "A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00742261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*